antibody against p-pi3k (tyr607 (Thermo Fisher)
Thermo Fisher is a verified supplier 
Thermo Fisher manufactures this product 
90
Structured Review
Thermo Fisher
antibody against p-pi3k (tyr607
Antibody Against P Pi3k (Tyr607, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/p%E2%80%90pi3k+(tyr607/pm37606338-39-40-45
Average 90 stars, based on 1 article reviews
Antibody Against P Pi3k (Tyr607, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/p%E2%80%90pi3k+(tyr607/pm37606338-39-40-45
Average 90 stars, based on 1 article reviews
antibody against p-pi3k (tyr607 - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
Immunohistochemistry:Article Title: Vildagliptin attenuates acetic acid-induced colitis in rats via targeting PI3K/Akt/NFκB, Nrf2 and CREB signaling pathways and the expression of lncRNA IFNG-AS1 and miR-146a. Article Snippet: Inflammatory processes, including ulcerative colitis (UC), are associated with the increase in synthesis and release of pro-inflammatory cytokines.. The release of these cytokines is regulated by phosphatidylinositol-3kinase (PI3K)/protein kinase B (Akt)/nuclear factor-kappa B (NFκB) and cAMP response element-binding protein (CREB) signaling pathways as well as over expression of microRNA 146a (miR-146a) and long non-coding RNA interferon gamma antisense 1 (lncRNA IFNG-AS1).. Vildagliptin (Vilda), a dipeptidyl peptidase IV (DPP-IV) inhibitor, has an anti-inflammatory, antioxidant and anti-apoptotic effects which were established in various models. Article Title: Selenium‐binding protein 1 inhibits malignant progression and induces apoptosis via distinct mechanisms in non‐small cell lung cancer Article Snippet: In IHC staining, the sections were deparaffinize, rehydrated, followed by antigen retrieval and immunostaining with different antibodies against SELENBP1 (1:200 dilution, Abcam, ab90135), SP‐C (1:200 dilution, Abcam, ab90716), Ki‐67 (1:200 dilution, Abcam, ab15580), PI3K (1:100 dilution, Abcam, ab151549), Article Title: Selenium-binding protein 1 inhibits malignant progression and induces apoptosis via distinct mechanisms in non-small cell lung cancer. Article Snippet: In IHC staining, the sections were deparaffinize, rehydrated, followed by antigen retrieval and immunostaining with different antibodies against SELENBP1 (1:200 dilution, Abcam, ab90135), SP- C (1:200 dilution, Abcam, ab90716), Ki- 67 (1:200 dilution, Abcam, ab15580), PI3K (1:100 dilution, Abcam, ab151549), Article Title: Protective effect of alogliptin against cyclophosphamide-induced lung toxicity in rats: Impact on PI3K/Akt/FoxO1 pathway and downstream inflammatory cascades Article Snippet: Afterwards, we incubate these membranes with polyclonal antibodies (1:1000): Article Title: Selenium‐binding protein 1 inhibits malignant progression and induces apoptosis via distinct mechanisms in non‐small cell lung cancer Article Snippet: Primary antibodies against β‐actin (1:1000 dilution, Abcam, ab8226), SELENBP1 (1:1000 dilution, Abcam, ab90135), PI3K (1:1000 dilution, Abcam, ab151549), Staining:Article Title: Vildagliptin attenuates acetic acid-induced colitis in rats via targeting PI3K/Akt/NFκB, Nrf2 and CREB signaling pathways and the expression of lncRNA IFNG-AS1 and miR-146a. Article Snippet: Inflammatory processes, including ulcerative colitis (UC), are associated with the increase in synthesis and release of pro-inflammatory cytokines.. The release of these cytokines is regulated by phosphatidylinositol-3kinase (PI3K)/protein kinase B (Akt)/nuclear factor-kappa B (NFκB) and cAMP response element-binding protein (CREB) signaling pathways as well as over expression of microRNA 146a (miR-146a) and long non-coding RNA interferon gamma antisense 1 (lncRNA IFNG-AS1).. Vildagliptin (Vilda), a dipeptidyl peptidase IV (DPP-IV) inhibitor, has an anti-inflammatory, antioxidant and anti-apoptotic effects which were established in various models. Article Title: Selenium‐binding protein 1 inhibits malignant progression and induces apoptosis via distinct mechanisms in non‐small cell lung cancer Article Snippet: In IHC staining, the sections were deparaffinize, rehydrated, followed by antigen retrieval and immunostaining with different antibodies against SELENBP1 (1:200 dilution, Abcam, ab90135), SP‐C (1:200 dilution, Abcam, ab90716), Ki‐67 (1:200 dilution, Abcam, ab15580), PI3K (1:100 dilution, Abcam, ab151549), Article Title: Selenium-binding protein 1 inhibits malignant progression and induces apoptosis via distinct mechanisms in non-small cell lung cancer. Article Snippet: In IHC staining, the sections were deparaffinize, rehydrated, followed by antigen retrieval and immunostaining with different antibodies against SELENBP1 (1:200 dilution, Abcam, ab90135), SP- C (1:200 dilution, Abcam, ab90716), Ki- 67 (1:200 dilution, Abcam, ab15580), PI3K (1:100 dilution, Abcam, ab151549), Article Title: Protective effect of alogliptin against cyclophosphamide-induced lung toxicity in rats: Impact on PI3K/Akt/FoxO1 pathway and downstream inflammatory cascades Article Snippet: Afterwards, we incubate these membranes with polyclonal antibodies (1:1000): Article Title: Selenium‐binding protein 1 inhibits malignant progression and induces apoptosis via distinct mechanisms in non‐small cell lung cancer Article Snippet: Primary antibodies against β‐actin (1:1000 dilution, Abcam, ab8226), SELENBP1 (1:1000 dilution, Abcam, ab90135), PI3K (1:1000 dilution, Abcam, ab151549), Immunostaining:Article Title: Vildagliptin attenuates acetic acid-induced colitis in rats via targeting PI3K/Akt/NFκB, Nrf2 and CREB signaling pathways and the expression of lncRNA IFNG-AS1 and miR-146a. Article Snippet: Inflammatory processes, including ulcerative colitis (UC), are associated with the increase in synthesis and release of pro-inflammatory cytokines.. The release of these cytokines is regulated by phosphatidylinositol-3kinase (PI3K)/protein kinase B (Akt)/nuclear factor-kappa B (NFκB) and cAMP response element-binding protein (CREB) signaling pathways as well as over expression of microRNA 146a (miR-146a) and long non-coding RNA interferon gamma antisense 1 (lncRNA IFNG-AS1).. Vildagliptin (Vilda), a dipeptidyl peptidase IV (DPP-IV) inhibitor, has an anti-inflammatory, antioxidant and anti-apoptotic effects which were established in various models. Article Title: Selenium‐binding protein 1 inhibits malignant progression and induces apoptosis via distinct mechanisms in non‐small cell lung cancer Article Snippet: In IHC staining, the sections were deparaffinize, rehydrated, followed by antigen retrieval and immunostaining with different antibodies against SELENBP1 (1:200 dilution, Abcam, ab90135), SP‐C (1:200 dilution, Abcam, ab90716), Ki‐67 (1:200 dilution, Abcam, ab15580), PI3K (1:100 dilution, Abcam, ab151549), Article Title: Selenium-binding protein 1 inhibits malignant progression and induces apoptosis via distinct mechanisms in non-small cell lung cancer. Article Snippet: In IHC staining, the sections were deparaffinize, rehydrated, followed by antigen retrieval and immunostaining with different antibodies against SELENBP1 (1:200 dilution, Abcam, ab90135), SP- C (1:200 dilution, Abcam, ab90716), Ki- 67 (1:200 dilution, Abcam, ab15580), PI3K (1:100 dilution, Abcam, ab151549), Article Title: Protective effect of alogliptin against cyclophosphamide-induced lung toxicity in rats: Impact on PI3K/Akt/FoxO1 pathway and downstream inflammatory cascades Article Snippet: Afterwards, we incubate these membranes with polyclonal antibodies (1:1000): Article Title: Selenium‐binding protein 1 inhibits malignant progression and induces apoptosis via distinct mechanisms in non‐small cell lung cancer Article Snippet: Primary antibodies against β‐actin (1:1000 dilution, Abcam, ab8226), SELENBP1 (1:1000 dilution, Abcam, ab90135), PI3K (1:1000 dilution, Abcam, ab151549), Over Expression:Article Title: Vildagliptin attenuates acetic acid-induced colitis in rats via targeting PI3K/Akt/NFκB, Nrf2 and CREB signaling pathways and the expression of lncRNA IFNG-AS1 and miR-146a. Article Snippet: Inflammatory processes, including ulcerative colitis (UC), are associated with the increase in synthesis and release of pro-inflammatory cytokines.. The release of these cytokines is regulated by phosphatidylinositol-3kinase (PI3K)/protein kinase B (Akt)/nuclear factor-kappa B (NFκB) and cAMP response element-binding protein (CREB) signaling pathways as well as over expression of microRNA 146a (miR-146a) and long non-coding RNA interferon gamma antisense 1 (lncRNA IFNG-AS1).. Vildagliptin (Vilda), a dipeptidyl peptidase IV (DPP-IV) inhibitor, has an anti-inflammatory, antioxidant and anti-apoptotic effects which were established in various models. Article Title: Selenium‐binding protein 1 inhibits malignant progression and induces apoptosis via distinct mechanisms in non‐small cell lung cancer Article Snippet: In IHC staining, the sections were deparaffinize, rehydrated, followed by antigen retrieval and immunostaining with different antibodies against SELENBP1 (1:200 dilution, Abcam, ab90135), SP‐C (1:200 dilution, Abcam, ab90716), Ki‐67 (1:200 dilution, Abcam, ab15580), PI3K (1:100 dilution, Abcam, ab151549), Article Title: Selenium-binding protein 1 inhibits malignant progression and induces apoptosis via distinct mechanisms in non-small cell lung cancer. Article Snippet: In IHC staining, the sections were deparaffinize, rehydrated, followed by antigen retrieval and immunostaining with different antibodies against SELENBP1 (1:200 dilution, Abcam, ab90135), SP- C (1:200 dilution, Abcam, ab90716), Ki- 67 (1:200 dilution, Abcam, ab15580), PI3K (1:100 dilution, Abcam, ab151549), Article Title: Protective effect of alogliptin against cyclophosphamide-induced lung toxicity in rats: Impact on PI3K/Akt/FoxO1 pathway and downstream inflammatory cascades Article Snippet: Afterwards, we incubate these membranes with polyclonal antibodies (1:1000): Article Title: Selenium‐binding protein 1 inhibits malignant progression and induces apoptosis via distinct mechanisms in non‐small cell lung cancer Article Snippet: Primary antibodies against β‐actin (1:1000 dilution, Abcam, ab8226), SELENBP1 (1:1000 dilution, Abcam, ab90135), PI3K (1:1000 dilution, Abcam, ab151549), Migration:Article Title: Vildagliptin attenuates acetic acid-induced colitis in rats via targeting PI3K/Akt/NFκB, Nrf2 and CREB signaling pathways and the expression of lncRNA IFNG-AS1 and miR-146a. Article Snippet: Inflammatory processes, including ulcerative colitis (UC), are associated with the increase in synthesis and release of pro-inflammatory cytokines.. The release of these cytokines is regulated by phosphatidylinositol-3kinase (PI3K)/protein kinase B (Akt)/nuclear factor-kappa B (NFκB) and cAMP response element-binding protein (CREB) signaling pathways as well as over expression of microRNA 146a (miR-146a) and long non-coding RNA interferon gamma antisense 1 (lncRNA IFNG-AS1).. Vildagliptin (Vilda), a dipeptidyl peptidase IV (DPP-IV) inhibitor, has an anti-inflammatory, antioxidant and anti-apoptotic effects which were established in various models. Article Title: Selenium‐binding protein 1 inhibits malignant progression and induces apoptosis via distinct mechanisms in non‐small cell lung cancer Article Snippet: In IHC staining, the sections were deparaffinize, rehydrated, followed by antigen retrieval and immunostaining with different antibodies against SELENBP1 (1:200 dilution, Abcam, ab90135), SP‐C (1:200 dilution, Abcam, ab90716), Ki‐67 (1:200 dilution, Abcam, ab15580), PI3K (1:100 dilution, Abcam, ab151549), Article Title: Selenium-binding protein 1 inhibits malignant progression and induces apoptosis via distinct mechanisms in non-small cell lung cancer. Article Snippet: In IHC staining, the sections were deparaffinize, rehydrated, followed by antigen retrieval and immunostaining with different antibodies against SELENBP1 (1:200 dilution, Abcam, ab90135), SP- C (1:200 dilution, Abcam, ab90716), Ki- 67 (1:200 dilution, Abcam, ab15580), PI3K (1:100 dilution, Abcam, ab151549), Article Title: Protective effect of alogliptin against cyclophosphamide-induced lung toxicity in rats: Impact on PI3K/Akt/FoxO1 pathway and downstream inflammatory cascades Article Snippet: Afterwards, we incubate these membranes with polyclonal antibodies (1:1000): Article Title: Selenium‐binding protein 1 inhibits malignant progression and induces apoptosis via distinct mechanisms in non‐small cell lung cancer Article Snippet: Primary antibodies against β‐actin (1:1000 dilution, Abcam, ab8226), SELENBP1 (1:1000 dilution, Abcam, ab90135), PI3K (1:1000 dilution, Abcam, ab151549), In Vitro:Article Title: Vildagliptin attenuates acetic acid-induced colitis in rats via targeting PI3K/Akt/NFκB, Nrf2 and CREB signaling pathways and the expression of lncRNA IFNG-AS1 and miR-146a. Article Snippet: Inflammatory processes, including ulcerative colitis (UC), are associated with the increase in synthesis and release of pro-inflammatory cytokines.. The release of these cytokines is regulated by phosphatidylinositol-3kinase (PI3K)/protein kinase B (Akt)/nuclear factor-kappa B (NFκB) and cAMP response element-binding protein (CREB) signaling pathways as well as over expression of microRNA 146a (miR-146a) and long non-coding RNA interferon gamma antisense 1 (lncRNA IFNG-AS1).. Vildagliptin (Vilda), a dipeptidyl peptidase IV (DPP-IV) inhibitor, has an anti-inflammatory, antioxidant and anti-apoptotic effects which were established in various models. Article Title: Selenium‐binding protein 1 inhibits malignant progression and induces apoptosis via distinct mechanisms in non‐small cell lung cancer Article Snippet: In IHC staining, the sections were deparaffinize, rehydrated, followed by antigen retrieval and immunostaining with different antibodies against SELENBP1 (1:200 dilution, Abcam, ab90135), SP‐C (1:200 dilution, Abcam, ab90716), Ki‐67 (1:200 dilution, Abcam, ab15580), PI3K (1:100 dilution, Abcam, ab151549), Article Title: Selenium-binding protein 1 inhibits malignant progression and induces apoptosis via distinct mechanisms in non-small cell lung cancer. Article Snippet: In IHC staining, the sections were deparaffinize, rehydrated, followed by antigen retrieval and immunostaining with different antibodies against SELENBP1 (1:200 dilution, Abcam, ab90135), SP- C (1:200 dilution, Abcam, ab90716), Ki- 67 (1:200 dilution, Abcam, ab15580), PI3K (1:100 dilution, Abcam, ab151549), Article Title: Protective effect of alogliptin against cyclophosphamide-induced lung toxicity in rats: Impact on PI3K/Akt/FoxO1 pathway and downstream inflammatory cascades Article Snippet: Afterwards, we incubate these membranes with polyclonal antibodies (1:1000): Article Title: Selenium‐binding protein 1 inhibits malignant progression and induces apoptosis via distinct mechanisms in non‐small cell lung cancer Article Snippet: Primary antibodies against β‐actin (1:1000 dilution, Abcam, ab8226), SELENBP1 (1:1000 dilution, Abcam, ab90135), PI3K (1:1000 dilution, Abcam, ab151549), Western Blot:Article Title: Vildagliptin attenuates acetic acid-induced colitis in rats via targeting PI3K/Akt/NFκB, Nrf2 and CREB signaling pathways and the expression of lncRNA IFNG-AS1 and miR-146a. Article Snippet: Inflammatory processes, including ulcerative colitis (UC), are associated with the increase in synthesis and release of pro-inflammatory cytokines.. The release of these cytokines is regulated by phosphatidylinositol-3kinase (PI3K)/protein kinase B (Akt)/nuclear factor-kappa B (NFκB) and cAMP response element-binding protein (CREB) signaling pathways as well as over expression of microRNA 146a (miR-146a) and long non-coding RNA interferon gamma antisense 1 (lncRNA IFNG-AS1).. Vildagliptin (Vilda), a dipeptidyl peptidase IV (DPP-IV) inhibitor, has an anti-inflammatory, antioxidant and anti-apoptotic effects which were established in various models. Article Title: Selenium‐binding protein 1 inhibits malignant progression and induces apoptosis via distinct mechanisms in non‐small cell lung cancer Article Snippet: In IHC staining, the sections were deparaffinize, rehydrated, followed by antigen retrieval and immunostaining with different antibodies against SELENBP1 (1:200 dilution, Abcam, ab90135), SP‐C (1:200 dilution, Abcam, ab90716), Ki‐67 (1:200 dilution, Abcam, ab15580), PI3K (1:100 dilution, Abcam, ab151549), Article Title: Selenium-binding protein 1 inhibits malignant progression and induces apoptosis via distinct mechanisms in non-small cell lung cancer. Article Snippet: In IHC staining, the sections were deparaffinize, rehydrated, followed by antigen retrieval and immunostaining with different antibodies against SELENBP1 (1:200 dilution, Abcam, ab90135), SP- C (1:200 dilution, Abcam, ab90716), Ki- 67 (1:200 dilution, Abcam, ab15580), PI3K (1:100 dilution, Abcam, ab151549), Article Title: Protective effect of alogliptin against cyclophosphamide-induced lung toxicity in rats: Impact on PI3K/Akt/FoxO1 pathway and downstream inflammatory cascades Article Snippet: Afterwards, we incubate these membranes with polyclonal antibodies (1:1000): Article Title: Selenium‐binding protein 1 inhibits malignant progression and induces apoptosis via distinct mechanisms in non‐small cell lung cancer Article Snippet: Primary antibodies against β‐actin (1:1000 dilution, Abcam, ab8226), SELENBP1 (1:1000 dilution, Abcam, ab90135), PI3K (1:1000 dilution, Abcam, ab151549), Transwell Assay:Article Title: Vildagliptin attenuates acetic acid-induced colitis in rats via targeting PI3K/Akt/NFκB, Nrf2 and CREB signaling pathways and the expression of lncRNA IFNG-AS1 and miR-146a. Article Snippet: Inflammatory processes, including ulcerative colitis (UC), are associated with the increase in synthesis and release of pro-inflammatory cytokines.. The release of these cytokines is regulated by phosphatidylinositol-3kinase (PI3K)/protein kinase B (Akt)/nuclear factor-kappa B (NFκB) and cAMP response element-binding protein (CREB) signaling pathways as well as over expression of microRNA 146a (miR-146a) and long non-coding RNA interferon gamma antisense 1 (lncRNA IFNG-AS1).. Vildagliptin (Vilda), a dipeptidyl peptidase IV (DPP-IV) inhibitor, has an anti-inflammatory, antioxidant and anti-apoptotic effects which were established in various models. Article Title: Selenium‐binding protein 1 inhibits malignant progression and induces apoptosis via distinct mechanisms in non‐small cell lung cancer Article Snippet: In IHC staining, the sections were deparaffinize, rehydrated, followed by antigen retrieval and immunostaining with different antibodies against SELENBP1 (1:200 dilution, Abcam, ab90135), SP‐C (1:200 dilution, Abcam, ab90716), Ki‐67 (1:200 dilution, Abcam, ab15580), PI3K (1:100 dilution, Abcam, ab151549), Article Title: Selenium-binding protein 1 inhibits malignant progression and induces apoptosis via distinct mechanisms in non-small cell lung cancer. Article Snippet: In IHC staining, the sections were deparaffinize, rehydrated, followed by antigen retrieval and immunostaining with different antibodies against SELENBP1 (1:200 dilution, Abcam, ab90135), SP- C (1:200 dilution, Abcam, ab90716), Ki- 67 (1:200 dilution, Abcam, ab15580), PI3K (1:100 dilution, Abcam, ab151549), Article Title: Protective effect of alogliptin against cyclophosphamide-induced lung toxicity in rats: Impact on PI3K/Akt/FoxO1 pathway and downstream inflammatory cascades Article Snippet: Afterwards, we incubate these membranes with polyclonal antibodies (1:1000): Article Title: Selenium‐binding protein 1 inhibits malignant progression and induces apoptosis via distinct mechanisms in non‐small cell lung cancer Article Snippet: Primary antibodies against β‐actin (1:1000 dilution, Abcam, ab8226), SELENBP1 (1:1000 dilution, Abcam, ab90135), PI3K (1:1000 dilution, Abcam, ab151549), In Vivo:Article Title: Vildagliptin attenuates acetic acid-induced colitis in rats via targeting PI3K/Akt/NFκB, Nrf2 and CREB signaling pathways and the expression of lncRNA IFNG-AS1 and miR-146a. Article Snippet: Inflammatory processes, including ulcerative colitis (UC), are associated with the increase in synthesis and release of pro-inflammatory cytokines.. The release of these cytokines is regulated by phosphatidylinositol-3kinase (PI3K)/protein kinase B (Akt)/nuclear factor-kappa B (NFκB) and cAMP response element-binding protein (CREB) signaling pathways as well as over expression of microRNA 146a (miR-146a) and long non-coding RNA interferon gamma antisense 1 (lncRNA IFNG-AS1).. Vildagliptin (Vilda), a dipeptidyl peptidase IV (DPP-IV) inhibitor, has an anti-inflammatory, antioxidant and anti-apoptotic effects which were established in various models. Article Title: Selenium‐binding protein 1 inhibits malignant progression and induces apoptosis via distinct mechanisms in non‐small cell lung cancer Article Snippet: In IHC staining, the sections were deparaffinize, rehydrated, followed by antigen retrieval and immunostaining with different antibodies against SELENBP1 (1:200 dilution, Abcam, ab90135), SP‐C (1:200 dilution, Abcam, ab90716), Ki‐67 (1:200 dilution, Abcam, ab15580), PI3K (1:100 dilution, Abcam, ab151549), Article Title: Selenium-binding protein 1 inhibits malignant progression and induces apoptosis via distinct mechanisms in non-small cell lung cancer. Article Snippet: In IHC staining, the sections were deparaffinize, rehydrated, followed by antigen retrieval and immunostaining with different antibodies against SELENBP1 (1:200 dilution, Abcam, ab90135), SP- C (1:200 dilution, Abcam, ab90716), Ki- 67 (1:200 dilution, Abcam, ab15580), PI3K (1:100 dilution, Abcam, ab151549), Article Title: Protective effect of alogliptin against cyclophosphamide-induced lung toxicity in rats: Impact on PI3K/Akt/FoxO1 pathway and downstream inflammatory cascades Article Snippet: Afterwards, we incubate these membranes with polyclonal antibodies (1:1000): Article Title: Selenium‐binding protein 1 inhibits malignant progression and induces apoptosis via distinct mechanisms in non‐small cell lung cancer Article Snippet: Primary antibodies against β‐actin (1:1000 dilution, Abcam, ab8226), SELENBP1 (1:1000 dilution, Abcam, ab90135), PI3K (1:1000 dilution, Abcam, ab151549), Inhibition:Article Title: Vildagliptin attenuates acetic acid-induced colitis in rats via targeting PI3K/Akt/NFκB, Nrf2 and CREB signaling pathways and the expression of lncRNA IFNG-AS1 and miR-146a. Article Snippet: Inflammatory processes, including ulcerative colitis (UC), are associated with the increase in synthesis and release of pro-inflammatory cytokines.. The release of these cytokines is regulated by phosphatidylinositol-3kinase (PI3K)/protein kinase B (Akt)/nuclear factor-kappa B (NFκB) and cAMP response element-binding protein (CREB) signaling pathways as well as over expression of microRNA 146a (miR-146a) and long non-coding RNA interferon gamma antisense 1 (lncRNA IFNG-AS1).. Vildagliptin (Vilda), a dipeptidyl peptidase IV (DPP-IV) inhibitor, has an anti-inflammatory, antioxidant and anti-apoptotic effects which were established in various models. Article Title: Selenium‐binding protein 1 inhibits malignant progression and induces apoptosis via distinct mechanisms in non‐small cell lung cancer Article Snippet: In IHC staining, the sections were deparaffinize, rehydrated, followed by antigen retrieval and immunostaining with different antibodies against SELENBP1 (1:200 dilution, Abcam, ab90135), SP‐C (1:200 dilution, Abcam, ab90716), Ki‐67 (1:200 dilution, Abcam, ab15580), PI3K (1:100 dilution, Abcam, ab151549), Article Title: Selenium-binding protein 1 inhibits malignant progression and induces apoptosis via distinct mechanisms in non-small cell lung cancer. Article Snippet: In IHC staining, the sections were deparaffinize, rehydrated, followed by antigen retrieval and immunostaining with different antibodies against SELENBP1 (1:200 dilution, Abcam, ab90135), SP- C (1:200 dilution, Abcam, ab90716), Ki- 67 (1:200 dilution, Abcam, ab15580), PI3K (1:100 dilution, Abcam, ab151549), Article Title: Protective effect of alogliptin against cyclophosphamide-induced lung toxicity in rats: Impact on PI3K/Akt/FoxO1 pathway and downstream inflammatory cascades Article Snippet: Afterwards, we incubate these membranes with polyclonal antibodies (1:1000): Article Title: Selenium‐binding protein 1 inhibits malignant progression and induces apoptosis via distinct mechanisms in non‐small cell lung cancer Article Snippet: Primary antibodies against β‐actin (1:1000 dilution, Abcam, ab8226), SELENBP1 (1:1000 dilution, Abcam, ab90135), PI3K (1:1000 dilution, Abcam, ab151549), Injection:Article Title: Vildagliptin attenuates acetic acid-induced colitis in rats via targeting PI3K/Akt/NFκB, Nrf2 and CREB signaling pathways and the expression of lncRNA IFNG-AS1 and miR-146a. Article Snippet: Inflammatory processes, including ulcerative colitis (UC), are associated with the increase in synthesis and release of pro-inflammatory cytokines.. The release of these cytokines is regulated by phosphatidylinositol-3kinase (PI3K)/protein kinase B (Akt)/nuclear factor-kappa B (NFκB) and cAMP response element-binding protein (CREB) signaling pathways as well as over expression of microRNA 146a (miR-146a) and long non-coding RNA interferon gamma antisense 1 (lncRNA IFNG-AS1).. Vildagliptin (Vilda), a dipeptidyl peptidase IV (DPP-IV) inhibitor, has an anti-inflammatory, antioxidant and anti-apoptotic effects which were established in various models. Article Title: Selenium‐binding protein 1 inhibits malignant progression and induces apoptosis via distinct mechanisms in non‐small cell lung cancer Article Snippet: In IHC staining, the sections were deparaffinize, rehydrated, followed by antigen retrieval and immunostaining with different antibodies against SELENBP1 (1:200 dilution, Abcam, ab90135), SP‐C (1:200 dilution, Abcam, ab90716), Ki‐67 (1:200 dilution, Abcam, ab15580), PI3K (1:100 dilution, Abcam, ab151549), Article Title: Selenium-binding protein 1 inhibits malignant progression and induces apoptosis via distinct mechanisms in non-small cell lung cancer. Article Snippet: In IHC staining, the sections were deparaffinize, rehydrated, followed by antigen retrieval and immunostaining with different antibodies against SELENBP1 (1:200 dilution, Abcam, ab90135), SP- C (1:200 dilution, Abcam, ab90716), Ki- 67 (1:200 dilution, Abcam, ab15580), PI3K (1:100 dilution, Abcam, ab151549), Article Title: Protective effect of alogliptin against cyclophosphamide-induced lung toxicity in rats: Impact on PI3K/Akt/FoxO1 pathway and downstream inflammatory cascades Article Snippet: Afterwards, we incubate these membranes with polyclonal antibodies (1:1000): Article Title: Selenium‐binding protein 1 inhibits malignant progression and induces apoptosis via distinct mechanisms in non‐small cell lung cancer Article Snippet: Primary antibodies against β‐actin (1:1000 dilution, Abcam, ab8226), SELENBP1 (1:1000 dilution, Abcam, ab90135), PI3K (1:1000 dilution, Abcam, ab151549), Microscopy:Article Title: Vildagliptin attenuates acetic acid-induced colitis in rats via targeting PI3K/Akt/NFκB, Nrf2 and CREB signaling pathways and the expression of lncRNA IFNG-AS1 and miR-146a. Article Snippet: Inflammatory processes, including ulcerative colitis (UC), are associated with the increase in synthesis and release of pro-inflammatory cytokines.. The release of these cytokines is regulated by phosphatidylinositol-3kinase (PI3K)/protein kinase B (Akt)/nuclear factor-kappa B (NFκB) and cAMP response element-binding protein (CREB) signaling pathways as well as over expression of microRNA 146a (miR-146a) and long non-coding RNA interferon gamma antisense 1 (lncRNA IFNG-AS1).. Vildagliptin (Vilda), a dipeptidyl peptidase IV (DPP-IV) inhibitor, has an anti-inflammatory, antioxidant and anti-apoptotic effects which were established in various models. Article Title: Selenium‐binding protein 1 inhibits malignant progression and induces apoptosis via distinct mechanisms in non‐small cell lung cancer Article Snippet: In IHC staining, the sections were deparaffinize, rehydrated, followed by antigen retrieval and immunostaining with different antibodies against SELENBP1 (1:200 dilution, Abcam, ab90135), SP‐C (1:200 dilution, Abcam, ab90716), Ki‐67 (1:200 dilution, Abcam, ab15580), PI3K (1:100 dilution, Abcam, ab151549), Article Title: Selenium-binding protein 1 inhibits malignant progression and induces apoptosis via distinct mechanisms in non-small cell lung cancer. Article Snippet: In IHC staining, the sections were deparaffinize, rehydrated, followed by antigen retrieval and immunostaining with different antibodies against SELENBP1 (1:200 dilution, Abcam, ab90135), SP- C (1:200 dilution, Abcam, ab90716), Ki- 67 (1:200 dilution, Abcam, ab15580), PI3K (1:100 dilution, Abcam, ab151549), Article Title: Protective effect of alogliptin against cyclophosphamide-induced lung toxicity in rats: Impact on PI3K/Akt/FoxO1 pathway and downstream inflammatory cascades Article Snippet: Afterwards, we incubate these membranes with polyclonal antibodies (1:1000): Article Title: Selenium‐binding protein 1 inhibits malignant progression and induces apoptosis via distinct mechanisms in non‐small cell lung cancer Article Snippet: Primary antibodies against β‐actin (1:1000 dilution, Abcam, ab8226), SELENBP1 (1:1000 dilution, Abcam, ab90135), PI3K (1:1000 dilution, Abcam, ab151549), Expressing:Article Title: Vildagliptin attenuates acetic acid-induced colitis in rats via targeting PI3K/Akt/NFκB, Nrf2 and CREB signaling pathways and the expression of lncRNA IFNG-AS1 and miR-146a. Article Snippet: Inflammatory processes, including ulcerative colitis (UC), are associated with the increase in synthesis and release of pro-inflammatory cytokines.. The release of these cytokines is regulated by phosphatidylinositol-3kinase (PI3K)/protein kinase B (Akt)/nuclear factor-kappa B (NFκB) and cAMP response element-binding protein (CREB) signaling pathways as well as over expression of microRNA 146a (miR-146a) and long non-coding RNA interferon gamma antisense 1 (lncRNA IFNG-AS1).. Vildagliptin (Vilda), a dipeptidyl peptidase IV (DPP-IV) inhibitor, has an anti-inflammatory, antioxidant and anti-apoptotic effects which were established in various models. Article Title: Selenium‐binding protein 1 inhibits malignant progression and induces apoptosis via distinct mechanisms in non‐small cell lung cancer Article Snippet: In IHC staining, the sections were deparaffinize, rehydrated, followed by antigen retrieval and immunostaining with different antibodies against SELENBP1 (1:200 dilution, Abcam, ab90135), SP‐C (1:200 dilution, Abcam, ab90716), Ki‐67 (1:200 dilution, Abcam, ab15580), PI3K (1:100 dilution, Abcam, ab151549), Article Title: Selenium-binding protein 1 inhibits malignant progression and induces apoptosis via distinct mechanisms in non-small cell lung cancer. Article Snippet: In IHC staining, the sections were deparaffinize, rehydrated, followed by antigen retrieval and immunostaining with different antibodies against SELENBP1 (1:200 dilution, Abcam, ab90135), SP- C (1:200 dilution, Abcam, ab90716), Ki- 67 (1:200 dilution, Abcam, ab15580), PI3K (1:100 dilution, Abcam, ab151549), Article Title: Protective effect of alogliptin against cyclophosphamide-induced lung toxicity in rats: Impact on PI3K/Akt/FoxO1 pathway and downstream inflammatory cascades Article Snippet: Afterwards, we incubate these membranes with polyclonal antibodies (1:1000): Article Title: Selenium‐binding protein 1 inhibits malignant progression and induces apoptosis via distinct mechanisms in non‐small cell lung cancer Article Snippet: Primary antibodies against β‐actin (1:1000 dilution, Abcam, ab8226), SELENBP1 (1:1000 dilution, Abcam, ab90135), PI3K (1:1000 dilution, Abcam, ab151549), Activation Assay:Article Title: Vildagliptin attenuates acetic acid-induced colitis in rats via targeting PI3K/Akt/NFκB, Nrf2 and CREB signaling pathways and the expression of lncRNA IFNG-AS1 and miR-146a. Article Snippet: Inflammatory processes, including ulcerative colitis (UC), are associated with the increase in synthesis and release of pro-inflammatory cytokines.. The release of these cytokines is regulated by phosphatidylinositol-3kinase (PI3K)/protein kinase B (Akt)/nuclear factor-kappa B (NFκB) and cAMP response element-binding protein (CREB) signaling pathways as well as over expression of microRNA 146a (miR-146a) and long non-coding RNA interferon gamma antisense 1 (lncRNA IFNG-AS1).. Vildagliptin (Vilda), a dipeptidyl peptidase IV (DPP-IV) inhibitor, has an anti-inflammatory, antioxidant and anti-apoptotic effects which were established in various models. Article Title: Selenium‐binding protein 1 inhibits malignant progression and induces apoptosis via distinct mechanisms in non‐small cell lung cancer Article Snippet: In IHC staining, the sections were deparaffinize, rehydrated, followed by antigen retrieval and immunostaining with different antibodies against SELENBP1 (1:200 dilution, Abcam, ab90135), SP‐C (1:200 dilution, Abcam, ab90716), Ki‐67 (1:200 dilution, Abcam, ab15580), PI3K (1:100 dilution, Abcam, ab151549), Article Title: Selenium-binding protein 1 inhibits malignant progression and induces apoptosis via distinct mechanisms in non-small cell lung cancer. Article Snippet: In IHC staining, the sections were deparaffinize, rehydrated, followed by antigen retrieval and immunostaining with different antibodies against SELENBP1 (1:200 dilution, Abcam, ab90135), SP- C (1:200 dilution, Abcam, ab90716), Ki- 67 (1:200 dilution, Abcam, ab15580), PI3K (1:100 dilution, Abcam, ab151549), Article Title: Protective effect of alogliptin against cyclophosphamide-induced lung toxicity in rats: Impact on PI3K/Akt/FoxO1 pathway and downstream inflammatory cascades Article Snippet: Afterwards, we incubate these membranes with polyclonal antibodies (1:1000): Article Title: Selenium‐binding protein 1 inhibits malignant progression and induces apoptosis via distinct mechanisms in non‐small cell lung cancer Article Snippet: Primary antibodies against β‐actin (1:1000 dilution, Abcam, ab8226), SELENBP1 (1:1000 dilution, Abcam, ab90135), PI3K (1:1000 dilution, Abcam, ab151549), Incubation:Article Title: Vildagliptin attenuates acetic acid-induced colitis in rats via targeting PI3K/Akt/NFκB, Nrf2 and CREB signaling pathways and the expression of lncRNA IFNG-AS1 and miR-146a. Article Snippet: Inflammatory processes, including ulcerative colitis (UC), are associated with the increase in synthesis and release of pro-inflammatory cytokines.. The release of these cytokines is regulated by phosphatidylinositol-3kinase (PI3K)/protein kinase B (Akt)/nuclear factor-kappa B (NFκB) and cAMP response element-binding protein (CREB) signaling pathways as well as over expression of microRNA 146a (miR-146a) and long non-coding RNA interferon gamma antisense 1 (lncRNA IFNG-AS1).. Vildagliptin (Vilda), a dipeptidyl peptidase IV (DPP-IV) inhibitor, has an anti-inflammatory, antioxidant and anti-apoptotic effects which were established in various models. Article Title: Selenium‐binding protein 1 inhibits malignant progression and induces apoptosis via distinct mechanisms in non‐small cell lung cancer Article Snippet: In IHC staining, the sections were deparaffinize, rehydrated, followed by antigen retrieval and immunostaining with different antibodies against SELENBP1 (1:200 dilution, Abcam, ab90135), SP‐C (1:200 dilution, Abcam, ab90716), Ki‐67 (1:200 dilution, Abcam, ab15580), PI3K (1:100 dilution, Abcam, ab151549), Article Title: Selenium-binding protein 1 inhibits malignant progression and induces apoptosis via distinct mechanisms in non-small cell lung cancer. Article Snippet: In IHC staining, the sections were deparaffinize, rehydrated, followed by antigen retrieval and immunostaining with different antibodies against SELENBP1 (1:200 dilution, Abcam, ab90135), SP- C (1:200 dilution, Abcam, ab90716), Ki- 67 (1:200 dilution, Abcam, ab15580), PI3K (1:100 dilution, Abcam, ab151549), Article Title: Protective effect of alogliptin against cyclophosphamide-induced lung toxicity in rats: Impact on PI3K/Akt/FoxO1 pathway and downstream inflammatory cascades Article Snippet: Afterwards, we incubate these membranes with polyclonal antibodies (1:1000): Article Title: Selenium‐binding protein 1 inhibits malignant progression and induces apoptosis via distinct mechanisms in non‐small cell lung cancer Article Snippet: Primary antibodies against β‐actin (1:1000 dilution, Abcam, ab8226), SELENBP1 (1:1000 dilution, Abcam, ab90135), PI3K (1:1000 dilution, Abcam, ab151549), Saline:Article Title: Vildagliptin attenuates acetic acid-induced colitis in rats via targeting PI3K/Akt/NFκB, Nrf2 and CREB signaling pathways and the expression of lncRNA IFNG-AS1 and miR-146a. Article Snippet: Inflammatory processes, including ulcerative colitis (UC), are associated with the increase in synthesis and release of pro-inflammatory cytokines.. The release of these cytokines is regulated by phosphatidylinositol-3kinase (PI3K)/protein kinase B (Akt)/nuclear factor-kappa B (NFκB) and cAMP response element-binding protein (CREB) signaling pathways as well as over expression of microRNA 146a (miR-146a) and long non-coding RNA interferon gamma antisense 1 (lncRNA IFNG-AS1).. Vildagliptin (Vilda), a dipeptidyl peptidase IV (DPP-IV) inhibitor, has an anti-inflammatory, antioxidant and anti-apoptotic effects which were established in various models. Article Title: Selenium‐binding protein 1 inhibits malignant progression and induces apoptosis via distinct mechanisms in non‐small cell lung cancer Article Snippet: In IHC staining, the sections were deparaffinize, rehydrated, followed by antigen retrieval and immunostaining with different antibodies against SELENBP1 (1:200 dilution, Abcam, ab90135), SP‐C (1:200 dilution, Abcam, ab90716), Ki‐67 (1:200 dilution, Abcam, ab15580), PI3K (1:100 dilution, Abcam, ab151549), Article Title: Selenium-binding protein 1 inhibits malignant progression and induces apoptosis via distinct mechanisms in non-small cell lung cancer. Article Snippet: In IHC staining, the sections were deparaffinize, rehydrated, followed by antigen retrieval and immunostaining with different antibodies against SELENBP1 (1:200 dilution, Abcam, ab90135), SP- C (1:200 dilution, Abcam, ab90716), Ki- 67 (1:200 dilution, Abcam, ab15580), PI3K (1:100 dilution, Abcam, ab151549), Article Title: Protective effect of alogliptin against cyclophosphamide-induced lung toxicity in rats: Impact on PI3K/Akt/FoxO1 pathway and downstream inflammatory cascades Article Snippet: Afterwards, we incubate these membranes with polyclonal antibodies (1:1000): Article Title: Selenium‐binding protein 1 inhibits malignant progression and induces apoptosis via distinct mechanisms in non‐small cell lung cancer Article Snippet: Primary antibodies against β‐actin (1:1000 dilution, Abcam, ab8226), SELENBP1 (1:1000 dilution, Abcam, ab90135), PI3K (1:1000 dilution, Abcam, ab151549), Control:Article Title: Vildagliptin attenuates acetic acid-induced colitis in rats via targeting PI3K/Akt/NFκB, Nrf2 and CREB signaling pathways and the expression of lncRNA IFNG-AS1 and miR-146a. Article Snippet: Inflammatory processes, including ulcerative colitis (UC), are associated with the increase in synthesis and release of pro-inflammatory cytokines.. The release of these cytokines is regulated by phosphatidylinositol-3kinase (PI3K)/protein kinase B (Akt)/nuclear factor-kappa B (NFκB) and cAMP response element-binding protein (CREB) signaling pathways as well as over expression of microRNA 146a (miR-146a) and long non-coding RNA interferon gamma antisense 1 (lncRNA IFNG-AS1).. Vildagliptin (Vilda), a dipeptidyl peptidase IV (DPP-IV) inhibitor, has an anti-inflammatory, antioxidant and anti-apoptotic effects which were established in various models. Article Title: Selenium‐binding protein 1 inhibits malignant progression and induces apoptosis via distinct mechanisms in non‐small cell lung cancer Article Snippet: In IHC staining, the sections were deparaffinize, rehydrated, followed by antigen retrieval and immunostaining with different antibodies against SELENBP1 (1:200 dilution, Abcam, ab90135), SP‐C (1:200 dilution, Abcam, ab90716), Ki‐67 (1:200 dilution, Abcam, ab15580), PI3K (1:100 dilution, Abcam, ab151549), Article Title: Selenium-binding protein 1 inhibits malignant progression and induces apoptosis via distinct mechanisms in non-small cell lung cancer. Article Snippet: In IHC staining, the sections were deparaffinize, rehydrated, followed by antigen retrieval and immunostaining with different antibodies against SELENBP1 (1:200 dilution, Abcam, ab90135), SP- C (1:200 dilution, Abcam, ab90716), Ki- 67 (1:200 dilution, Abcam, ab15580), PI3K (1:100 dilution, Abcam, ab151549), Article Title: Protective effect of alogliptin against cyclophosphamide-induced lung toxicity in rats: Impact on PI3K/Akt/FoxO1 pathway and downstream inflammatory cascades Article Snippet: Afterwards, we incubate these membranes with polyclonal antibodies (1:1000): Article Title: Selenium‐binding protein 1 inhibits malignant progression and induces apoptosis via distinct mechanisms in non‐small cell lung cancer Article Snippet: Primary antibodies against β‐actin (1:1000 dilution, Abcam, ab8226), SELENBP1 (1:1000 dilution, Abcam, ab90135), PI3K (1:1000 dilution, Abcam, ab151549), Blocking Assay:Article Title: Vildagliptin attenuates acetic acid-induced colitis in rats via targeting PI3K/Akt/NFκB, Nrf2 and CREB signaling pathways and the expression of lncRNA IFNG-AS1 and miR-146a. Article Snippet: Inflammatory processes, including ulcerative colitis (UC), are associated with the increase in synthesis and release of pro-inflammatory cytokines.. The release of these cytokines is regulated by phosphatidylinositol-3kinase (PI3K)/protein kinase B (Akt)/nuclear factor-kappa B (NFκB) and cAMP response element-binding protein (CREB) signaling pathways as well as over expression of microRNA 146a (miR-146a) and long non-coding RNA interferon gamma antisense 1 (lncRNA IFNG-AS1).. Vildagliptin (Vilda), a dipeptidyl peptidase IV (DPP-IV) inhibitor, has an anti-inflammatory, antioxidant and anti-apoptotic effects which were established in various models. Article Title: Selenium‐binding protein 1 inhibits malignant progression and induces apoptosis via distinct mechanisms in non‐small cell lung cancer Article Snippet: In IHC staining, the sections were deparaffinize, rehydrated, followed by antigen retrieval and immunostaining with different antibodies against SELENBP1 (1:200 dilution, Abcam, ab90135), SP‐C (1:200 dilution, Abcam, ab90716), Ki‐67 (1:200 dilution, Abcam, ab15580), PI3K (1:100 dilution, Abcam, ab151549), Article Title: Selenium-binding protein 1 inhibits malignant progression and induces apoptosis via distinct mechanisms in non-small cell lung cancer. Article Snippet: In IHC staining, the sections were deparaffinize, rehydrated, followed by antigen retrieval and immunostaining with different antibodies against SELENBP1 (1:200 dilution, Abcam, ab90135), SP- C (1:200 dilution, Abcam, ab90716), Ki- 67 (1:200 dilution, Abcam, ab15580), PI3K (1:100 dilution, Abcam, ab151549), Article Title: Protective effect of alogliptin against cyclophosphamide-induced lung toxicity in rats: Impact on PI3K/Akt/FoxO1 pathway and downstream inflammatory cascades Article Snippet: Afterwards, we incubate these membranes with polyclonal antibodies (1:1000): Article Title: Selenium‐binding protein 1 inhibits malignant progression and induces apoptosis via distinct mechanisms in non‐small cell lung cancer Article Snippet: Primary antibodies against β‐actin (1:1000 dilution, Abcam, ab8226), SELENBP1 (1:1000 dilution, Abcam, ab90135), PI3K (1:1000 dilution, Abcam, ab151549), |
